市場調查報告書

靜脈瘤治療的全球市場:成長,趨勢,及預測

Varicose Veins Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921278
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
靜脈瘤治療的全球市場:成長,趨勢,及預測 Varicose Veins Treatment Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 114 Pages
簡介

全球靜脈瘤治療市場成長,主要由於對微創手術的一般人口增加的趨勢,老年人口的增加,治療所使用的設備的技術進步等要素而受到推動。目前市場規模,北美和歐洲等的先進地區佔最高佔有率,不過,由於技術進步和對醫療系統的關注度高漲,大部分新興國家在預測期間內市場將踏實成長。

本報告提供全球靜脈瘤治療市場的相關調查,市場機會和趨勢,成長及阻礙因素,各治療類型、產品、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 微創手術的人氣高漲
    • 設備的技術進步
    • 部分國家的高潛在需求
  • 阻礙市場要素
    • 治療的成本高
    • 靜脈手術伴隨的風險
  • 波特的五力分析

第5章 市場區隔

  • 各治療類型
    • 靜脈內切除
    • 注射硬化療法
    • 外科的結紮/汽提
  • 各產品
    • 切除設備
    • 靜脈栓塞設備
    • 外科用品
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Syneron Medical Ltd.
    • Medtronic Plc
    • Lumenis
    • Quanta System
    • Teleflex Incorporated
    • Energist Ltd.
    • Eufoton srl
    • biolitec AG
    • AngioDynamics, Inc.

第7章 市場機會及今後趨勢

目錄
Product Code: 67124

Market Overview

The market for varicose veins is majorly driven by factors such as growing preference of the general population for minimally invasive surgeries, rising geriatric population, and the technological advancements in the devices used for this treatment.

It has been found that nearly 23% of the US adults are having varicose veins and it is more common in older women. Varicose veins affect 22 million women and 11 million men between the ages of 40 to 80 years. In the United Kingdom, diagnosis and treatment of varicose veins include a significant part of the surgical workload. In the UK, National Health Service waiting lists suggest that there is still a considerable unmet need which is posing an opportunity for the companies to establish a better market. Also, developing countries such as India and South Africa are also facing issues while dealing with the varicose veins as there are high unmet needs.

However, with the technological advancements and growing focus on the improvised healthcare system, it is believed that the market will witness steady growth over the forecast period in most of the developing nations. In terms of market size, developed regions such as North America and Europe hold the highest share.

Scope of the Report

Varicose veins are the superficial veins that become enlarged and twisted and are present under the skin in the legs. The varicose veins treatment market includes the type of treatment and the devices used for the same.

Key Market Trends

Laser Ablation Devices to Witness Considerable Growth Over the Forecast Period

Laser Ablation treatment does not include long hospital stays of discomfort during the recovery which is a positive factor for the patients who are being treated for this disease. The disease is treated with various types of treatment including self-treatment. However, with the help of novel technologies, there has been a large use of lasers for the varicose veins.

This new technology of lasers enables the doctors to close off the smaller varicose veins and spider veins. This treatment allows the strong bursts of light onto the vein making affected veins disappear or fade. The use of laser treatment is increasing across the developed nations as people are able to afford the cost of treatment required and there is no needle or incision is needed for this type of treatment. Also, there is a huge competition among the local laser manufacturers that are into the varicose vein lasers. With the upcoming advancements in lasers and the ease of treatment provided by the same, it is expected that the segment will grow in the future.

Furthermore, laser devices are also used widely for the treatment of diseases such as Peripheral Arterial Disease (PAD) which is a risk factor for the occurrence of varicose veins. Hence, it is indicated that the prevalence of PAD is also affecting the growth of laser devices for varicose veins in a positive manner.

North America Dominates the Market

North America holds the largest share of the market studied and it is believed to follow the same trend over the forecast period. The major factors contributing to the growth of this market in North America include the presence of the developed healthcare system in the United States and the presence of companies that allows easier product availability in the market. Furthermore, due to the favorable reimbursement scenario, people across the United States are able to get the treatment with less cost.

Added to that, the rising prevalence of varicose veins is another factor propelling the growth of the market studied. For instance, the prevalence of varicose veins given by the Chicago Vein Institute is around 55% in women and 45% in men across the United States. It has been suggested by the same institute that there are around 40 million people in the United States suffering from varicose veins.

Competitive Landscape

The market for varicose veins treatment is moderately competitive and comprises most of the local players. There are few international companies that are into this business but the overall market is majorly controlled by the local companies in different geographies. With the growing medical devices market, it is believed that more companies will penetrate the market and hold a substantial share over the forecast period.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Preference of Minimally Invasive Surgeries
    • 4.2.2 Technological Advancements in the Devices
    • 4.2.3 High Unmet Needs in Some Countries
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Procedure
    • 4.3.2 Risk Associated with the Vein Surgeries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Treatment Type
    • 5.1.1 Endovenous Ablation
    • 5.1.2 Injection Sclerotherapy
    • 5.1.3 Surgical Ligation/Stripping
  • 5.2 By Product
    • 5.2.1 Ablation Devices
      • 5.2.1.1 Radiofrequency Ablation Devices
      • 5.2.1.2 Laser Ablation Devices
    • 5.2.2 Venous Closure Products
    • 5.2.3 Surgical Products
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Syneron Medical Ltd.
    • 6.1.2 Medtronic Plc
    • 6.1.3 Lumenis
    • 6.1.4 Quanta System
    • 6.1.5 Teleflex Incorporated
    • 6.1.6 Energist Ltd.
    • 6.1.7 Eufoton s.r.l.
    • 6.1.8 biolitec AG
    • 6.1.9 AngioDynamics, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS